CD24 and cancer: Consequently, we first collected a panel of human MCL cell lines in order to assess CD24 surface expression by flow cytometry, showing heterogenous but higher levels of Median Fluorescence Intensity (MFI) if compared to CD24− cancer cell line (Figure S1).